Evidence map›Paper›PMID 40163485›Full record

ArticlePLOS global public health2025

Prediction models for Mtb infection among adolescent and adult household contacts in high tuberculosis incidence settings.

Edson Tawanda Marambire, Claire J Calderwood, Leyla Larsson, Kathrin Held, Palwasha Khan, Denise Banze, Celina Nhamuave, Lillian T Minja, Alfred Mfinanga, Rishi K Gupta and 4 more

Abstract read
In one paragraph

Article in PLOS global public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Edson Tawanda MarambireThe Health Research Unit Zimbabwe, Biomedical Research and Training Institute, Harare, Zimbabwe.ORCID https://orcid.org/0000-0001-5944-5010
Claire J CalderwoodThe Health Research Unit Zimbabwe, Biomedical Research and Training Institute, Harare, Zimbabwe.
Leyla LarssonInstitute of Infectious Diseases and Tropical Medicine, LMU University Hospital, LMU Munich, Munich, Germany.
Kathrin HeldInstitute of Infectious Diseases and Tropical Medicine, LMU University Hospital, LMU Munich, Munich, Germany.ORCID https://orcid.org/0000-0001-7057-6935
Palwasha KhanFaculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, United Kingdom.
Denise BanzeCIHLMU Center for International Health, University Hospital, LMU Munich, Germany.
Celina NhamuaveInstituto Nacional de Saúde, Marracuene, Mozambique.
Lillian T MinjaNational Institute for Medical Research - Mbeya Medical Research Centre, Mbeya, Tanzania.ORCID https://orcid.org/0000-0002-9597-0207
Alfred MfinangaCIHLMU Center for International Health, University Hospital, LMU Munich, Germany.
Rishi K GuptaUniversity College London, London, United Kingdom.
Celso KhosaInstituto Nacional de Saúde, Marracuene, Mozambique.
Junior MutsvangwaBiomedical Research and Training Institute, Harare, Zimbabwe.
Norbert HeinrichInstitute of Infectious Diseases and Tropical Medicine, LMU University Hospital, LMU Munich, Munich, Germany.
Katharina KranzerThe Health Research Unit Zimbabwe, Biomedical Research and Training Institute, Harare, Zimbabwe.

Funding

Wellcome Trust
6 · The paper itself

Abstract

Tuberculosis household contacts are at high risk of developing tuberculosis. Tuberculosis preventive therapy (TPT) is highly effective, but implementation is hindered by limited accessibility of diagnostic tests aimed at detecting Mycobacterium tuberculosis (Mtb) infection. Development of Mtb infection prediction models to guide clinical decision-making aims to overcome these challenges. We used data from 1905 tuberculosis household contacts (age ≥10 years) from Zimbabwe, Mozambique and Tanzania to develop two prediction models for Mtb infection determined by interferon-gamma release assay (IGRA) using logistic regression with backward elimination and cross-validation and converted these into a risk score. Model performance was assessed using area under the receiver operating characteristic curve (AUROC), sensitivity, and specificity. We developed a basic model with six predictors (age, caregiver role, index case symptom duration, index HIV status, household crowding, and index GeneXpert MTB/Rif results) and a comprehensive model with eleven predictors. The basic and comprehensive risk scores showed limited predictive capability (AUROC 0.592, sensitivity 76%, specificity 35% and AUROC 0.586, sensitivity 76%, specificity 36% respectively), with considerable overlap across IGRA-positive and -negative individuals. Neither model conferred net benefit over a treat-all strategy. Overall, our results suggest that the prediction models developed in this study do not add value for guiding TPT use in high-tuberculosis burden settings. This likely reflects complex Mtb transmission dynamics at the household- and community-level, variation in individual-level susceptibility and immune response, as well as limited accuracy of IGRA testing. Improved diagnostics to determine Mtb infection status in terms of ease-of-use, accuracy, and costs are needed.

Identifiers

PMID40163485
PMCPMC11957366

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.